NCT05292664 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05292664
Title	Venetoclax Basket Trial for High Risk Hematologic Malignancies
Recruitment	Active, not recruiting
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	Andrew E. Place
Indications	myelodysplastic syndrome acute myeloid leukemia acute biphenotypic leukemia B-cell acute lymphoblastic leukemia T-cell acute lymphoblastic leukemia lymphoblastic lymphoma
Therapies	Azacitidine + Cytarabine + Hydrocortisone + Leucovorin + Methotrexate + Venetoclax Calaspargase pegol-mknl + Cytarabine + Dexamethasone + Dexrazoxane + Doxorubicin + Hydrocortisone + Leucovorin + Methotrexate + Venetoclax + Vincristine Sulfate Azacitidine + Venetoclax
Age Groups:	adult \| child \| senior
Covered Countries	USA

Facility	City	State	Zip	Country	Details
University of California San Francisco-Benioff Children's Hospital	San Francisco	California	94158	United States	Details
Children's Hospital Colorado	Aurora	Colorado	80045	United States	Details
Children's Healthcare of Atlanta at Arthur M. Blank Hospital	Atlanta	Georgia	30329	United States	Details
Ann & Robert H Lurie Children's Hospital of Chicago	Chicago	Illinois	60611	United States	Details
Dana-Farber Cancer Institute	Boston	Massachusetts	02215	United States	Details

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT05292664Clinical Trial Detail